# FDA/FTC Compliance Software for IV Therapy Clinics - RegenCompliance

Purpose-built compliance scanning for IV therapy and wellness clinics. The IV therapy rule set - vitamin, NAD+, hydration, and mobile IV marketing checked against FDA drug-claim and FTC substantiation rules.

Canonical page: https://regencompliance.ai/for/iv-therapy


## Risk summary

IV therapy and vitamin-infusion clinics have been a growth category in both patient volume and enforcement interest. The FDA reads most IV therapy offerings under drug-regulatory authority (many IV formulations are legally drugs, whether branded or compounded). The FTC applies substantiation rules to every benefit claim - 'boosts immunity,' 'cures hangovers,' 'improves energy.' State boards of nursing and medicine scrutinize who can administer IVs, under what supervision, and what medical evaluation must precede treatment. And NAD+ marketing specifically has been a growing FTC focus. RegenCompliance is built to catch the specific patterns each authority targets.


## Real enforcement examples

- **FDA drug-claim enforcement on IV formulations**: IV formulations with specific active ingredients (glutathione, NAD+, certain compounded vitamin combinations) are legally drugs. Marketing them with disease-claim language ('treats,' 'cures,' 'prevents') triggers the same FDA drug-advertising rules as any prescription drug - a regulatory surface most IV clinics market as if it does not apply.
- **FTC substantiation enforcement on immune, energy, and hangover claims**: 'Boosts your immune system,' 'cures hangovers,' 'improves athletic performance' - these are all FTC substantiation targets. Clinical evidence for IV formulations meeting the FTC 'competent and reliable scientific evidence' bar is often sparse or absent. Marketing as if the evidence exists is a direct FTC pattern.
- **State nursing board actions on standing-order and supervision issues**: IV therapy clinics operating on standing orders, nurse-led mobile models, or non-physician-supervised structures have drawn state nursing and medical board attention in several states. Marketing language that minimizes medical-evaluation steps is a factor in enforcement.
- **FTC actions on NAD+ anti-aging and cognitive claims**: NAD+ marketing making anti-aging, cognitive enhancement, and longevity claims has been a specific FTC focus in 2024–2026. 'Reverses aging,' 'boosts cognition,' 'extends lifespan' on NAD+ product pages are active enforcement targets.
- **State AG actions on mobile IV pricing and consumer protection**: Mobile IV services have drawn state AG attention on advertised pricing (base rate vs. actual total) and consumer-protection disclosure. Marketing that advertises a base price without disclosure of add-ons has been cited.


## High-risk phrases and compliant alternatives

- **"Boosts your immune system"** (HIGH risk): Immune-boosting claims are FTC substantiation targets and often cross into drug-claim territory.
  - Compliant alternative: "Supports your body's normal immune function - actual results vary by individual"
- **"Cures hangovers"** (HIGH risk): Disease-cure claim on a category FTC has specifically targeted in IV marketing.
  - Compliant alternative: "May help support rehydration and recovery after dehydration"
- **"Reverses aging with NAD+"** (HIGH risk): Anti-aging reversal claim - direct FTC target in current NAD+ enforcement wave.
  - Compliant alternative: "Supports cellular metabolism - research on NAD+ biology continues"
- **"FDA-approved IV therapy"** (HIGH risk): Most IV formulations marketed by wellness clinics are not FDA-approved for the claimed indications.
  - Compliant alternative: "Administered by licensed medical professionals using [specific products or compounded formulations]"
- **"Guaranteed energy boost"** (HIGH risk): Guarantee claim without substantiation.
  - Compliant alternative: "Most of our patients report feeling more energized after treatment; individual experiences vary"
- **"Cures chronic fatigue"** (HIGH risk): Disease-cure claim on a specific medical diagnosis.
  - Compliant alternative: "May help support energy and wellness as part of a broader medical approach to chronic fatigue"
- **"10 years younger"** (HIGH risk): Quantified age-reversal claim without any clinical support.
  - Compliant alternative: "(Remove entirely - no compliant reframe for quantified age-reversal)"
- **"Pharmaceutical-grade"** (MEDIUM risk): Implies FDA approval or pharmaceutical-equivalency without substantiation.
  - Compliant alternative: "Prepared by a licensed compounding pharmacy meeting [specific standards]"
- **"Proven to improve performance"** (MEDIUM risk): 'Proven' requires clinical evidence meeting the FTC substantiation bar.
  - Compliant alternative: "Some athletes and active patients report perceived improvements; individual experiences vary"
- **"Weight loss IV"** (MEDIUM risk): Implies IV therapy as a weight-loss treatment - crosses into off-label drug marketing for compounded formulations.
  - Compliant alternative: "Some formulations may support metabolism as part of a broader weight management program under medical guidance"
- **"Celebrity favorite"** (HIGH risk): Implied endorsement without FTC material-connection disclosure.
  - Compliant alternative: "(Remove unless documented paid endorsement with proper disclosure)"
- **"Detox your body"** (MEDIUM risk): Detox claims are FTC substantiation targets; mechanism is rarely substantiable.
  - Compliant alternative: "Supports hydration and nutrient replenishment"


## Common mistakes

- **"Boosts your immune system"** (FTC substantiation under Section 5 (15 USC 45)): 'Immune-boosting' is the FTC's most-cited IV claim pattern. The substantiation bar is competent and reliable scientific evidence specific to the formulation and patient population - which IV therapy clinics essentially never have on file. RegenCompliance flags every immune-boost variant and rewrites to 'supports your body's normal immune function.'
- **"Cures hangovers"** (FDA disease-claim rule (21 USC 321(g))): Hangovers are technically a recognized condition; 'cure' on any condition is the FDA disease-claim trigger. Hangover IV marketing has produced direct FTC enforcement. We rewrite to 'may help support rehydration and recovery after dehydration.'
- **"Reverses aging with NAD+"** (FTC NAD+ enforcement priority (current)): NAD+ marketing with anti-aging reversal claims is the single most-active FTC IV-category enforcement target in 2026. We flag every NAD+ + reversal/longevity/anti-aging combination and rewrite to 'supports cellular metabolism - research on NAD+ biology continues.'
- **"FDA-approved IV therapy"** (FDA off-label promotion (21 CFR 202.1) + drug labeling): Most IV formulations marketed by wellness clinics are compounded preparations or off-label use - not FDA-approved for the marketed indications. Generic 'FDA-approved' across all IVs is direct misbranding. We rewrite to 'administered by licensed medical professionals using [specific products].'
- **"Detox your body"** (FTC substantiation - detox mechanism claims): Detox claims are an FTC-targeted category. The mechanism is rarely substantiable and the underlying physiology contradicts most marketed 'detox' descriptions. We rewrite to 'supports hydration and nutrient replenishment.'
- **"Pharmaceutical-grade"** (FDA labeling and substantiation - pharmaceutical equivalency): 'Pharmaceutical-grade' implies FDA approval or pharmaceutical-equivalency without substantiation. The phrase has no standardized regulatory definition for IV formulations. We rewrite to 'prepared by a licensed compounding pharmacy meeting [specific standards].'
- **"Cures chronic fatigue"** (FDA disease-claim rule (21 USC 321(g))): Chronic fatigue is a recognized medical diagnosis. 'Cure' on the diagnosis crosses the disease-claim threshold. We rewrite to 'may help support energy and wellness as part of a broader medical approach to chronic fatigue.'
- **"10 years younger"** (FTC substantiation - quantified age-reversal): Quantified age-reversal claims have zero clinical substantiation that meets the FTC bar for any IV formulation. There is no compliant reframing - we recommend complete removal of the quantified claim.
- **"Weight loss IV"** (FDA off-label drug-marketing (21 CFR 202.1)): Marketing IV formulations as weight-loss treatments crosses into off-label drug marketing for compounded preparations. State medical boards have additionally cited this pattern. We rewrite to 'metabolism-support formulations as part of a broader weight-management program under medical guidance.'
- **"Celebrity favorite"** (FTC Endorsement Guides (16 CFR 255)): Implied celebrity endorsement without documented material connection and required disclosures is a direct FTC violation. We flag implied-endorsement language and recommend either removal or proper paid-endorser disclosure.


## What the scanner catches

- **Menu-page benefit columns with disease/condition claims**: IV menu pages typically list each formulation with a benefit column - 'Immunity Boost: prevents colds, cures flu.' The condition-specific benefit column is where most disease claims enter IV marketing. Our scanner catches these systematically.
- **Social media ads for hangover, recovery, and party-goer IVs**: Hangover and party-recovery IV ads are an FTC focus area. Marketing these IVs specifically as hangover cures has triggered enforcement. Our scanner catches the common patterns and suggests lower-risk 'rehydration and recovery support' framings.
- **NAD+ marketing with anti-aging, longevity, and cognitive claims**: NAD+ is our single most-flagged IV category. Our rule set catches the reversal, longevity, cognitive, and energy-ageless framings that are under active FTC enforcement.
- **Athlete and performance IV marketing**: Performance IV marketing to athletes and active patients crosses into sports-supplement territory where FTC substantiation rules are strictly enforced. Our scanner catches quantified performance claims.
- **Mobile IV pricing disclosure issues**: Mobile IV services often advertise base prices without adequate disclosure of add-ons, service fees, and location surcharges - a state AG enforcement pattern. Our scanner catches missing-disclosure patterns and suggests standard-format disclosure language.


## Case study: A typical first scan on an IV therapy clinic menu page

Before: Our Immunity Boost IV cures colds and prevents flu. The Hangover Cure IV cures hangovers and reverses alcohol damage. Our NAD+ therapy reverses aging by 10 years, cures chronic fatigue, and is pharmaceutical-grade. Weight loss IV - guaranteed results, celebrity favorite, detoxes your body. FDA-approved formulations proven to improve performance.

After: Our Immunity Support IV is formulated to support your body's normal immune function - individual results vary. The Recovery IV is designed to support rehydration after dehydration. Our NAD+ infusion supports cellular metabolism - research into NAD+ biology continues, and individual experiences vary. Our metabolism-support formulations may be appropriate as part of a broader weight-management program under medical guidance. Administered by licensed medical professionals using formulations prepared by licensed compounding pharmacies. Most patients report feeling refreshed after treatment - individual results vary.

Outcome: Score went from 9 to 88 across 15 flagged phrases. Every core menu item retained - benefit language translated into substantiable framings that match FTC substantiation rules and current NAD+ enforcement patterns. PDF audit trail exported.


## Who this is for

- In-clinic IV therapy practices
- Mobile IV therapy services
- NAD+ and longevity-focused clinics
- Wellness and integrative medicine practices with IV offerings
- Med spa IV service lines
- Sports medicine and recovery-focused practices
- Franchise IV therapy operators
- Concierge medicine practices


## FAQ

### Are IV formulations legally drugs?

Most are. IV formulations with active pharmaceutical ingredients are drugs under FDA definition, whether branded (vitamin B12 injections under standard labeling) or compounded (custom formulations made by a licensed compounding pharmacy). Marketing them triggers FDA drug-advertising rules, which most IV clinics do not structure their marketing around. Our scanner catches the disease-claim, off-label, and unsubstantiated-efficacy patterns that those rules target.

### What about the NAD+ specific enforcement wave?

NAD+ is a current FTC focus. Marketing NAD+ with anti-aging reversal, cognitive enhancement, longevity, and cellular-damage-repair claims is under active enforcement. Our rule set specifically handles NAD+ marketing patterns and suggests framings that discuss NAD+ biology and cellular metabolism accurately without crossing into unsubstantiated efficacy or disease territory.

### Do FTC rules apply to IV therapy testimonials?

Yes - identically to any other healthcare testimonial. 'Your energy is back in 20 minutes,' 'your hangover cured,' 'feel 10 years younger' testimonials require typical-experience disclosures. Our scanner catches peak-outcome testimonials and suggests compliant framings.

### What about mobile IV services specifically?

Mobile IV services have additional exposure on pricing disclosure (base vs. actual total), supervision model (physician review of patient histories, nursing scope in your state), and marketing that implies on-demand prescribing. Our scanner catches the common patterns and suggests lower-risk alternatives, but state-specific supervision questions should involve counsel licensed in your state.

### Do the rules apply to my social media ads too?

Yes. Instagram and TikTok ads are the specific channels the FTC has called out for 2024–2026 enforcement priority. IV therapy is one of the most TikTok-heavy healthcare marketing categories. Our scanner treats short-form caption text the same as website copy - the rules apply to both.

### What about compounded formulations specifically?

Compounded formulations are legally distinct products from FDA-approved medications. Marketing them as equivalent to approved drugs is the same pattern that triggers enforcement in GLP-1 compounding. Our scanner flags compounded-to-approved equivalency language.

### Can I describe what is in each IV formulation?

Yes - accurate ingredient descriptions are generally safe. The issue is benefit/efficacy language, not ingredient language. 'Contains vitamin C, B-complex, and glutathione' is fine. 'Boosts immunity, fights illness, and prevents aging' is not. Our scanner separates the two.

### What about athlete and performance IV marketing?

Performance claims for athletes bring in an additional FTC substantiation surface and sometimes trigger anti-doping considerations. Our scanner catches the specific performance-claim patterns and suggests framings that describe hydration and nutrient support without unsubstantiated performance promises.

---

RegenCompliance is FDA/FTC compliance scanning software for healthcare marketing, operated by Regen Portal LLC. Educational compliance tool, not legal advice. Not affiliated with the FDA or FTC. Contact: support@regencompliance.ai. Full site index for AI agents: https://regencompliance.ai/llms.txt